| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.01 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.00079 | 1 |